Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Morgan Stanley has become a substantial holder in Australian Clinical Labs Limited, acquiring a 5.09% stake with 10,269,466 ordinary shares. The acquisition, which Morgan Stanley became aware of on September 18, 2024, includes shares held through various subsidiaries and involves both outright purchases and securities borrowed under agreements. The financial details of the transactions reveal a mix of cash payments and securities borrowing over recent months.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.